BREAKING
Clear Secure Jumps 6% Amid Sector-Wide Selling 4 minutes ago Veeco Instruments Jumps 7.4% Amid Sector-Wide Rally 46 minutes ago MaxLinear Surges 21.8% Amid Sector-Wide Selling 50 minutes ago Steel Dynamics Jumps 5.4% After Wells Fargo Main to Overweight 52 minutes ago Arcus Biosciences (RCUS) Drops 5.9% to $22.80 54 minutes ago Avis Budget Group Jumps 8.5% After Barclays Down to Underweight 58 minutes ago Norwegian Cruise Line Holdings Drops 5.5% After Stifel Main to Buy 2 hours ago Hims & Hers Health Jumps 8.8% After B of A Securities Main to Neutral 2 hours ago Oconee Federal Financial Releases Q1 2026 Financial Results 2 hours ago Dynex Capital Q1 2026 Loss Deepens: -$0.41/Share vs $0.35 Expected 2 hours ago Clear Secure Jumps 6% Amid Sector-Wide Selling 4 minutes ago Veeco Instruments Jumps 7.4% Amid Sector-Wide Rally 46 minutes ago MaxLinear Surges 21.8% Amid Sector-Wide Selling 50 minutes ago Steel Dynamics Jumps 5.4% After Wells Fargo Main to Overweight 52 minutes ago Arcus Biosciences (RCUS) Drops 5.9% to $22.80 54 minutes ago Avis Budget Group Jumps 8.5% After Barclays Down to Underweight 58 minutes ago Norwegian Cruise Line Holdings Drops 5.5% After Stifel Main to Buy 2 hours ago Hims & Hers Health Jumps 8.8% After B of A Securities Main to Neutral 2 hours ago Oconee Federal Financial Releases Q1 2026 Financial Results 2 hours ago Dynex Capital Q1 2026 Loss Deepens: -$0.41/Share vs $0.35 Expected 2 hours ago
ADVERTISEMENT
BIIB

Biogen Inc

$BIIB NASDAQ Apr 20, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

BIIB Coverage

Event Biogen Inc (BIIB) Sec Form 8K Apr 7, 2026 Event Biogen Inc (BIIB) Sec Form 8K Apr 1, 2026 Event Biogen Inc (BIIB) FDA Approves New High Dose Regimen of SPINRAZA (nusinersen) for Spinal Muscular Atrophy Mar 30, 2026 News Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook Feb 6, 2026 News Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% Feb 6, 2026 Transcript Biogen Inc (BIIB) Q4 2025 Earnings Call Transcript Jan 22, 2026 Transcript Biogen Inc (BIIB) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Biogen Inc (BIIB) Q3 2025 Earnings Call Transcript Jan 22, 2026